Skip to main content
Quest Diagnostics

Low Performance of Hepatitis Delta Virus Testing Among Two National Cohorts of Chronic Hepatitis B Patients in the United States

Low performance of hepatitis delta virus testing among two national cohorts of chronic hepatitis B patients in the United States

Authors: Wong RJ, Kaufman HW, Niles JK, Chen C, Yang Z, Kapoor H, Cheung R, Gish RG.

Citation: Am J Gastroenterol. 2022 Dec 1;117(12):2067-2070. doi: 10.14309/ajg.0000000000001947

Specialties: Infectious Disease

Download key summary

Related content

Conference Presentation
Very low rates of hepatitis delta virus testing among a large national cohort of patients with chronic hepatitis B infection
Publication
Simplifying Treatment Criteria in Chronic Hepatitis B: Reducing Barriers to Elimination
Publication
Prevalence of Hepatitis B Virus and Latent Tuberculosis CoInfection in the United States

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.